Tumor Metastasis by Hybridization

Courtesy of Media Services, Yale School of Medicine Left, a stained section of spontaneous lung metastasis showing normal lung tissue adjacent to melanoma tissue. Arrows delineate melanoma composed predominantly of melanin-containing cells. Right, cultured cells from spontaneous lung metastasis. Metastasis, the spread of cancer cells from primary tumor to new sites, often prevents successful cancer treatment. But how or why certain cells detach from a tumor, travel to distant locations in the bo

Written byNadia Halim
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Courtesy of Media Services, Yale School of Medicine

Left, a stained section of spontaneous lung metastasis showing normal lung tissue adjacent to melanoma tissue. Arrows delineate melanoma composed predominantly of melanin-containing cells. Right, cultured cells from spontaneous lung metastasis.
Metastasis, the spread of cancer cells from primary tumor to new sites, often prevents successful cancer treatment. But how or why certain cells detach from a tumor, travel to distant locations in the body, and establish a new tumor is still unclear. "We are talking about a couple of cells out of millions, but that is all it takes [to successfully create a secondary tumor]," explains Vincent Hearing, chief of the pigment cell biology section, National Cancer Institute.

John Pawelek, senior research scientist in dermatology at Yale University, and colleagues report this month on a mechanism that may initiate melanoma metastasis.1 They provide the first direct evidence that host-tumor hybridization may ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies